期刊文献+

Effect of maternal age on the outcomes of in vitro fertilization and embryo transfer(IVF-ET) 被引量:24

Effect of maternal age on the outcomes of in vitro fertilization and embryo transfer(IVF-ET)
原文传递
导出
摘要 This is a retrospective,observational study to evaluate the effect of maternal age on the outcomes of in vitro fertilization and embryo transfer(IVF-ET).11830 IVF-ET cycles from 10268 women were included.Four groups of different maternal age periods were compared.The groups were 21 30 years old group(4549 cycles),31-35 years old group(4424 cycles),36-40 years old group(2429 cycles),and over 40 years old group(428 cycles).The mean starting dose of Gn and mean total dose of Gn in each cycle were significantly higher(P<0.01),while the mean retrieved oocyte number was significantly lower(P<0.01) in groups of higher maternal age period than those in each of the lower groups.The biochemical pregnancy rate and the clinical pregnancy rate were significantly lower(P<0.01),while the miscarriage rate was significantly higher(P<0.01) in groups of higher maternal age period than those in the lower groups.No difference was found in two-pronuclear zygotes(2PN) rate and good quality embryo rate among different groups.Birth defect rate was also comparable in the born babies in different groups.In the group with patients' age over 40 years old,the pregnancy rate was 26.87%,the clinical pregnancy rate was 19.39%,while the miscarriage rate after clinical pregnancy was 36.14%.To draw the conclusion,patients with higher maternal age had worse IVF outcomes.In women of fertile age,patients between 20 and 30 years old have the best IVF outcomes.Patients over 40 years old have poor IVF outcome and high miscarriage rate,which suggested the necessity of preimplantation genetic screening(PGS). This is a retrospective,observational study to evaluate the effect of maternal age on the outcomes of in vitro fertilization and embryo transfer(IVF-ET).11830 IVF-ET cycles from 10268 women were included.Four groups of different maternal age periods were compared.The groups were 21 30 years old group(4549 cycles),31-35 years old group(4424 cycles),36-40 years old group(2429 cycles),and over 40 years old group(428 cycles).The mean starting dose of Gn and mean total dose of Gn in each cycle were significantly higher(P〈0.01),while the mean retrieved oocyte number was significantly lower(P〈0.01) in groups of higher maternal age period than those in each of the lower groups.The biochemical pregnancy rate and the clinical pregnancy rate were significantly lower(P〈0.01),while the miscarriage rate was significantly higher(P〈0.01) in groups of higher maternal age period than those in the lower groups.No difference was found in two-pronuclear zygotes(2PN) rate and good quality embryo rate among different groups.Birth defect rate was also comparable in the born babies in different groups.In the group with patients' age over 40 years old,the pregnancy rate was 26.87%,the clinical pregnancy rate was 19.39%,while the miscarriage rate after clinical pregnancy was 36.14%.To draw the conclusion,patients with higher maternal age had worse IVF outcomes.In women of fertile age,patients between 20 and 30 years old have the best IVF outcomes.Patients over 40 years old have poor IVF outcome and high miscarriage rate,which suggested the necessity of preimplantation genetic screening(PGS).
出处 《Science China(Life Sciences)》 SCIE CAS 2012年第8期694-698,共5页 中国科学(生命科学英文版)
关键词 IVF-ET 生育年龄 胚胎移植 体外授精 产妇 妊娠率 流产率 卵母细胞 in vitro fertilization,outcome,pregnancy rate,miscarriage rate,birth defect,maternal age
  • 相关文献

参考文献30

  • 1Gnoth C, Maxrath B, Skonieczny T, et al. Final ART success rates: a 10 years survey. Hum Reprod, 2011, 26: 2239-2246.
  • 2de Mouzon J, Goossens V, Bhattacharya S, et al. Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod, 2010, 25: 1851-1862.
  • 3Balasch J. Ageing and infertility: an overview. Gynecol Endocrinol, 2010, 26: 855-860.
  • 4Tatone C. Oocyte senescence: a firm link to age-related female subfertility. Gynecol Endocrinol, 2008, 24: 59-63.
  • 5Hassold T, Chen N, Funkhouser J, et al. A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet, 1980, 44: 151-178.
  • 6Thum M Y, Abdalla H I, Taylor D. Relationship between women’s age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment. Fertil Steril, 2008, 90: 315-321.
  • 7Yan J, Huang G, Sun Y, et al. Birth defects after assisted reproductive technologies in China: analysis of 15,405 offspring in seven centers (2004 to 2008). Fertil Steril, 2011, 95: 458-460.
  • 8Hourvitz A, Machtinger R, Maman E, et al. Assisted reproduction in women over 40 years of age: how old is too old? Reprod Biomed Online, 2009, 19: 599-603.
  • 9Griffiths A, Dyer S M, Lord S J, et al. A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts. Hum Reprod, 2010, 25: 924-931.
  • 10Vincent-Rohfritsch A, Le Ray C, Anselem O, et al. Pregnancy in women aged 43 years or older: Maternal and perinatal risks. J Gynecol Obstet Biol Reprod (Paris), 2012 (in press).

同被引文献117

引证文献24

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部